Median Technologies Is Moving Forward With the FDA Interactions for Its iBiopsy Lung Cancer Screening CADe/CADx Software as Medical Device

Median has received the FDA's feedback following the 513(g) regulatory submission for its iBiopsy LCS CADe/CADx Software as Medical Device. Median will proceed through a 510(k) submission

Related Keywords

United States ,Shanghai ,China ,Paris ,France General ,France ,French ,Cade Cadx ,Emmanuelle Leygues ,Lcs Cade Cadx ,Ghislaine Gasparetto ,Caroline Carmagnol ,Radiological Computer Assisted Detection And Diagnosis Software ,Head Of Corporate Marketing Financial Communications ,Software As Medical Device Sa ,Ai Software As Medical Device ,Drug Administration ,Biopsy Cade Cadx Software As Medical Device ,United States Food ,Biopsy Lung Cancer Screening ,Medical Device ,Median Technologies ,Fredrik Brag ,Artificial Intelligence ,Data Science ,Euronext Growth ,Euronext European Rising Tech ,Corporate Marketing Financial Communications ,Comedian ,Technologies ,Moving ,Forward ,Ith ,Interactions ,Biopsy ,Young ,Dancer ,Screening ,Rade ,Wadx ,Software ,Medical ,Device ,